Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

HSA Approval

HOSOLVON TABLET 8 mg

Approval Number

SIN05034P

Drug Name

HOSOLVON TABLET 8 mg

Product Name

HOSOLVON TABLET 8 mg

Approval Date

August 30, 1990

Registrant

GOLDPLUS UNIVERSAL PTE LTD

Licence Holder

GOLDPLUS UNIVERSAL PTE LTD

Regulatory Information

Registrant

GOLDPLUS UNIVERSAL PTE LTD

Licence Holder

GOLDPLUS UNIVERSAL PTE LTD

Drug Type

Therapeutic

Forensic Classification

Prescription Only

Formulation Information

Dosage Form

TABLET

Route of Administration

ORAL

Medical Information

ATC Code

R05CB02

ATC Item Name

bromhexine

Manufacturer Information

Pharmaceutical Manufacturer

GOLDPLUS UNIVERSAL PTE LTD

Manufacturers

HOVID BHD

HOVID Bhd.

Active Ingredients

Ingredient Name

BROMHEXINE HYDROCHLORIDE

Strength

8.00mg

Drug MonographBromhexine

Documents

Package Inserts

Hosolvon PI.pdf

Approved: April 28, 2017

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy

HOSOLVON TABLET 8 mg - HSA Approval | MedPath